{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/67458"},"canonical_url":"https://search.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/67458","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"The Mammary Gland in Health and Disease","abstract":"The mammary gland is a conserved, defining feature among mammals; however, there is much variation between species in both healthy functions, such as lactation, and diseases, such as mammary cancer and mastitis. Species such as the cow, for example, are expert lactators, while lactation insufficiency remains a problem for many women. Mammary cancer is common in species such as humans, dogs and cats, but is rare in other species such as horses, cows and pigs. The majority of this work focuses on mammary stem/progenitor (MaSC) cells as these are the cells thought to drive lactation and to be at least partly responsible for mammary cancer development. These cells have been successfully isolated and characterized in mice, humans, and cows; however, these methods use species-specific antibodies and thus cannot be broadly applied across species. We first describe a novel method for isolating and characterizing MaSC from many different species in an antibody-independent manner. We then describe two projects that use this method for a comparative species approach to define possible underlying mechanisms behind mammary cancer resistance. In the second project we discovered that the secretome of equine MaSC kills a subset of human breast cancer cells, establishing the potential therapeutic effects of the MaSC secretome. With this in mind, we focused on the other primary disease of the mammary gland: mastitis, an inflammatory disease most commonly caused by bacterial infections. We found that the secretome of bovine MaSC repairs epithelial and endothelial cell damage and contains antimicrobial peptides, making it a good option for complementary mastitis therapy. In our final project, we once again demonstrate the advantages of using a comparative species approach to identify potential treatments for canine and feline mammary cancer, modeled after what has previously been described for breast cancer in humans. Collectively, this work denotes two potential mechanisms for cancer resistance in domestic species and highlights the potential therapeutic benefits of the MaSC secretome.","abstract_html":"The mammary gland is a conserved, defining feature among mammals; however, there is much variation between species in both healthy functions, such as lactation, and diseases, such as mammary cancer and mastitis. Species such as the cow, for example, are expert lactators, while lactation insufficiency remains a problem for many women. Mammary cancer is common in species such as humans, dogs and cats, but is rare in other species such as horses, cows and pigs. The majority of this work focuses on mammary stem/progenitor (MaSC) cells as these are the cells thought to drive lactation and to be at least partly responsible for mammary cancer development. These cells have been successfully isolated and characterized in mice, humans, and cows; however, these methods use species-specific antibodies and thus cannot be broadly applied across species. We first describe a novel method for isolating and characterizing MaSC from many different species in an antibody-independent manner. We then describe two projects that use this method for a comparative species approach to define possible underlying mechanisms behind mammary cancer resistance. In the second project we discovered that the secretome of equine MaSC kills a subset of human breast cancer cells, establishing the potential therapeutic effects of the MaSC secretome. With this in mind, we focused on the other primary disease of the mammary gland: mastitis, an inflammatory disease most commonly caused by bacterial infections. We found that the secretome of bovine MaSC repairs epithelial and endothelial cell damage and contains antimicrobial peptides, making it a good option for complementary mastitis therapy. In our final project, we once again demonstrate the advantages of using a comparative species approach to identify potential treatments for canine and feline mammary cancer, modeled after what has previously been described for breast cancer in humans. Collectively, this work denotes two potential mechanisms for cancer resistance in domestic species and highlights the potential therapeutic benefits of the MaSC secretome.","abstract_has_math":false,"creators":["Ledet, Melissa McDowell"],"institution":"Cornell University","degree_name":"Ph.D., Biomedical and Biological Sciences","degree_level":"Doctor of Philosophy","degree_discipline":"Biomedical and Biological Sciences","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":["Van de Walle, Gerlinde"],"committee_members":["Weiss, Robert S.","Coonrod, Scott A.","Kurpios, Natasza"],"year":2019,"date_issued":"2019-05-30","date_published":"2019-05-30","updated_at":"2026-11-19T03:20:50Z","subjects":["Cellular biology"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/eb50-7261"],"render_values":[{"text":"https://doi.org/10.7298/eb50-7261","href":"https://doi.org/10.7298/eb50-7261","code":true}]},{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["11050440"],"render_values":[{"text":"11050440","href":null,"code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 11306","ProQuest Publication ID: 13808253"],"render_values":[{"text":"ProQuest Submission ID: 11306","href":null,"code":true},{"text":"ProQuest Publication ID: 13808253","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1813/67458","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1813/67458","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://ecommons.cornell.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aecommons.cornell.edu%3A1813%2F67458","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.chair","label":"Chair","values":["Van de Walle, Gerlinde"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Weiss, Robert S.","Coonrod, Scott A.","Kurpios, Natasza"]},{"key":"dc:creator","label":"Author","values":["Ledet, Melissa McDowell"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2019-10-15T15:32:28Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2020-06-05T06:01:44Z"]},{"key":"dc:date.issued","label":"Date","values":["2019-05-30"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical and Biological Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctor of Philosophy"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D., Biomedical and Biological Sciences"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cellular biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["11050440"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/eb50-7261"]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 11306","ProQuest Publication ID: 13808253"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/67458"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"cerif:openaire","label":"Cerif Openaire","values":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"ff956dad-8ef5-46c2-8d26-05495ea29a0e\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en_US</Language> <Title>The Mammary Gland in Health and Disease</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2019-05-30</PublicationDate> <DOI>https://doi.org/10.7298/eb50-7261</DOI> <Authors> <Author> <DisplayName>Ledet, Melissa McDowell</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>Cellular biology</Keyword> <Abstract>The mammary gland is a conserved, defining feature among mammals; however, there is much variation between species in both healthy functions, such as lactation, and diseases, such as mammary cancer and mastitis. Species such as the cow, for example, are expert lactators, while lactation insufficiency remains a problem for many women. Mammary cancer is common in species such as humans, dogs and cats, but is rare in other species such as horses, cows and pigs. The majority of this work focuses on mammary stem/progenitor (MaSC) cells as these are the cells thought to drive lactation and to be at least partly responsible for mammary cancer development. These cells have been successfully isolated and characterized in mice, humans, and cows; however, these methods use species-specific antibodies and thus cannot be broadly applied across species. We first describe a novel method for isolating and characterizing MaSC from many different species in an antibody-independent manner. We then describe two projects that use this method for a comparative species approach to define possible underlying mechanisms behind mammary cancer resistance. In the second project we discovered that the secretome of equine MaSC kills a subset of human breast cancer cells, establishing the potential therapeutic effects of the MaSC secretome. With this in mind, we focused on the other primary disease of the mammary gland: mastitis, an inflammatory disease most commonly caused by bacterial infections. We found that the secretome of bovine MaSC repairs epithelial and endothelial cell damage and contains antimicrobial peptides, making it a good option for complementary mastitis therapy. In our final project, we once again demonstrate the advantages of using a comparative species approach to identify potential treatments for canine and feline mammary cancer, modeled after what has previously been described for breast cancer in humans. Collectively, this work denotes two potential mechanisms for cancer resistance in domestic species and highlights the potential therapeutic benefits of the MaSC secretome.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"]},{"key":"cris:virtual.author","label":"Cris Virtual Author","values":["Ledet, Melissa McDowell"]},{"key":"cris:virtualsource.collection","label":"Cris Virtualsource Collection","values":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"]},{"key":"dc:description.abstract","label":"Abstract","values":["The mammary gland is a conserved, defining feature among mammals; however, there is much variation between species in both healthy functions, such as lactation, and diseases, such as mammary cancer and mastitis. Species such as the cow, for example, are expert lactators, while lactation insufficiency remains a problem for many women. Mammary cancer is common in species such as humans, dogs and cats, but is rare in other species such as horses, cows and pigs. The majority of this work focuses on mammary stem/progenitor (MaSC) cells as these are the cells thought to drive lactation and to be at least partly responsible for mammary cancer development. These cells have been successfully isolated and characterized in mice, humans, and cows; however, these methods use species-specific antibodies and thus cannot be broadly applied across species. We first describe a novel method for isolating and characterizing MaSC from many different species in an antibody-independent manner. We then describe two projects that use this method for a comparative species approach to define possible underlying mechanisms behind mammary cancer resistance. In the second project we discovered that the secretome of equine MaSC kills a subset of human breast cancer cells, establishing the potential therapeutic effects of the MaSC secretome. With this in mind, we focused on the other primary disease of the mammary gland: mastitis, an inflammatory disease most commonly caused by bacterial infections. We found that the secretome of bovine MaSC repairs epithelial and endothelial cell damage and contains antimicrobial peptides, making it a good option for complementary mastitis therapy. In our final project, we once again demonstrate the advantages of using a comparative species approach to identify potential treatments for canine and feline mammary cancer, modeled after what has previously been described for breast cancer in humans. Collectively, this work denotes two potential mechanisms for cancer resistance in domestic species and highlights the potential therapeutic benefits of the MaSC secretome."]},{"key":"dc:description.collection","label":"Dc Description Collection","values":["Cornell Theses and Dissertations"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dcterms:license","label":"Dcterms License","values":["https://hdl.handle.net/1813/59810"]},{"key":"dc:title","label":"Title","values":["The Mammary Gland in Health and Disease"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"cerif:openaire":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"ff956dad-8ef5-46c2-8d26-05495ea29a0e\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en_US</Language> <Title>The Mammary Gland in Health and Disease</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2019-05-30</PublicationDate> <DOI>https://doi.org/10.7298/eb50-7261</DOI> <Authors> <Author> <DisplayName>Ledet, Melissa McDowell</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>Cellular biology</Keyword> <Abstract>The mammary gland is a conserved, defining feature among mammals; however, there is much variation between species in both healthy functions, such as lactation, and diseases, such as mammary cancer and mastitis. Species such as the cow, for example, are expert lactators, while lactation insufficiency remains a problem for many women. Mammary cancer is common in species such as humans, dogs and cats, but is rare in other species such as horses, cows and pigs. The majority of this work focuses on mammary stem/progenitor (MaSC) cells as these are the cells thought to drive lactation and to be at least partly responsible for mammary cancer development. These cells have been successfully isolated and characterized in mice, humans, and cows; however, these methods use species-specific antibodies and thus cannot be broadly applied across species. We first describe a novel method for isolating and characterizing MaSC from many different species in an antibody-independent manner. We then describe two projects that use this method for a comparative species approach to define possible underlying mechanisms behind mammary cancer resistance. In the second project we discovered that the secretome of equine MaSC kills a subset of human breast cancer cells, establishing the potential therapeutic effects of the MaSC secretome. With this in mind, we focused on the other primary disease of the mammary gland: mastitis, an inflammatory disease most commonly caused by bacterial infections. We found that the secretome of bovine MaSC repairs epithelial and endothelial cell damage and contains antimicrobial peptides, making it a good option for complementary mastitis therapy. In our final project, we once again demonstrate the advantages of using a comparative species approach to identify potential treatments for canine and feline mammary cancer, modeled after what has previously been described for breast cancer in humans. Collectively, this work denotes two potential mechanisms for cancer resistance in domestic species and highlights the potential therapeutic benefits of the MaSC secretome.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"],"cris:virtual.author":["Ledet, Melissa McDowell"],"cris:virtualsource.collection":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"],"dc:contributor.chair":["Van de Walle, Gerlinde"],"dc:contributor.committeemember":["Weiss, Robert S.","Coonrod, Scott A.","Kurpios, Natasza"],"dc:creator":["Ledet, Melissa McDowell"],"dc:date.accessioned":["2019-10-15T15:32:28Z"],"dc:date.available":["2020-06-05T06:01:44Z"],"dc:date.issued":["2019-05-30"],"dc:description.abstract":["The mammary gland is a conserved, defining feature among mammals; however, there is much variation between species in both healthy functions, such as lactation, and diseases, such as mammary cancer and mastitis. Species such as the cow, for example, are expert lactators, while lactation insufficiency remains a problem for many women. Mammary cancer is common in species such as humans, dogs and cats, but is rare in other species such as horses, cows and pigs. The majority of this work focuses on mammary stem/progenitor (MaSC) cells as these are the cells thought to drive lactation and to be at least partly responsible for mammary cancer development. These cells have been successfully isolated and characterized in mice, humans, and cows; however, these methods use species-specific antibodies and thus cannot be broadly applied across species. We first describe a novel method for isolating and characterizing MaSC from many different species in an antibody-independent manner. We then describe two projects that use this method for a comparative species approach to define possible underlying mechanisms behind mammary cancer resistance. In the second project we discovered that the secretome of equine MaSC kills a subset of human breast cancer cells, establishing the potential therapeutic effects of the MaSC secretome. With this in mind, we focused on the other primary disease of the mammary gland: mastitis, an inflammatory disease most commonly caused by bacterial infections. We found that the secretome of bovine MaSC repairs epithelial and endothelial cell damage and contains antimicrobial peptides, making it a good option for complementary mastitis therapy. In our final project, we once again demonstrate the advantages of using a comparative species approach to identify potential treatments for canine and feline mammary cancer, modeled after what has previously been described for breast cancer in humans. Collectively, this work denotes two potential mechanisms for cancer resistance in domestic species and highlights the potential therapeutic benefits of the MaSC secretome."],"dc:description.collection":["Cornell Theses and Dissertations"],"dc:format.mimetype":["application/pdf"],"dc:identifier.bibid":["11050440"],"dc:identifier.doi":["https://doi.org/10.7298/eb50-7261"],"dc:identifier.other":["ProQuest Submission ID: 11306","ProQuest Publication ID: 13808253"],"dc:identifier.uri":["https://hdl.handle.net/1813/67458"],"dc:language.iso":["en_US"],"dc:subject":["Cellular biology"],"dcterms:license":["https://hdl.handle.net/1813/59810"],"dc:title":["The Mammary Gland in Health and Disease"],"dc:type":["dissertation or thesis"],"dspace:entity.type":["Publication"],"others:access_status":["open.access"],"thesis:degree_discipline":["Biomedical and Biological Sciences"],"thesis:degree_level":["Doctor of Philosophy"],"thesis:degree_name":["Ph.D., Biomedical and Biological Sciences"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-11-19T03:20:50Z"}